Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
December 17, 2018 - Shire announced the FDA approval of Motegrity (prucalopride), for the treatment of chronic idiopathic constipation (CIC) in adults.
